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Polonium-210 (210Po) gained widespread notoriety after the poisoning and subsequent death of 17 
Mr Alexander Litvinenko in London in 2006. Exposure to polonium-210 resulted initially in a 18 
clinical course that was indistinguishable from infection or exposure to chemical toxins, such as 19 
thallium.  20 
Methods 21 
A 43-year-old man presented to his local hospital with acute abdominal pain, diarrhoea and 22 
vomiting and was hospitalised because of dehydration and persistent gastrointestinal symptoms. 23 
He was initially diagnosed with gastroenteritis, and treated with antibiotics. Clostridium difficile 24 
toxin was subsequently detected in his stools, which is when he first raised the possibility of 25 
being poisoned and revealed his true identity, having been admitted under an alias. Within 6 26 
days the patient had developed thrombocytopenia and neutropenia, initially thought to be drug-27 
induced. By two weeks, in addition to bone marrow failure, there was evidence of alopecia and 28 
mucositis. Thallium poisoning was suspected and investigated but ultimately dismissed as blood 29 
levels were below toxic concentrations. The patient continued to deteriorate and within three 30 
weeks had developed multiple organ failure requiring ventilation, haemofiltration and cardiac 31 
support, associated with a drop in consciousness. On the 23rd day after he first fell ill, he suffered 32 
a pulseless electrical activity cardio-respiratory arrest from which he could not be resuscitated 33 
and was pronounced dead.  34 
Findings 35 
Urine analysis using gamma ray spectrometry showed a characteristic 803 keV photon emission, 36 
raising the possibility of 210Po poisoning on day 22. Results of confirmatory analysis that became 37 
available after his death established the presence of 210Po at concentrations about 109 times 38 
higher than normal background levels. Post-mortem tissue analyses showed autolysis and 39 
retention of 210Po at lethal doses in multiple organs. Based on the measured levels and tissue 40 
distribution of 210Po, it was estimated that the patient had ingested a dose of polonium chloride 41 
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salt, equivalent to 1,000 gigabecquerels (GBq), delivering very high and fatal radiation doses 42 
over a period of a few days.     43 
Interpretation 44 
Early symptoms of 210Po poisoning were indistinguishable from those of a wide range of chemical 45 
toxins. Hence, the diagnosis can be delayed and even missed without a high level of suspicion. 46 
Although body surface scanning with a standard Geiger counter was unable to detect the 47 
radiation emitted by 210Po, an atypical clinical course prompted active consideration of poisoning 48 
with radioactive material, with the diagnosis being ultimately made with gamma-ray spectroscopy 49 
of a urine sample.  50 
 51 
Introduction 52 
Alexander Litvinenko (born 4 December 1962) was an officer of the Russian secret service who, 53 
in 2000, was granted asylum in the United Kingdom and began working as a consultant for the 54 
British intelligence services. On 1 November 2006, Mr Litvinenko fell ill and was hospitalised. His 55 
illness was later attributed to poisoning with polonium-210 (210Po), as significant amounts of this 56 
highly toxic radionuclide were found in his body by the Health Protection Agency (now Public 57 
Health England). An inquest into Mr Litvinenko’s death was opened in November 2006 but was 58 
suspended pending conclusion of an inquiry established in July 2014. A public hearing 59 
commenced at the Royal Courts of Justice in London in January 2015 and included review of the 60 
patient’s medical records, clinical course, spectroscopy results, and statements by experts. The 61 
hearing concluded on 31 July 2015 and the final report into the death of Mr Litvinenko is 62 
expected to be delivered to the British Home Secretary by the end of 2015.  63 
 64 
Following the public hearing we the primary clinicians and toxicology experts involved in the care 65 
of Mr Litvinenko in 2006 are now free of any restrictions to describe the clinical aspects of this 66 
highly unusual case. In this report, we provide a first-hand account of the events leading to the 67 
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diagnosis of 210Po poisoning as well as detailed toxico-kinetics of this, the first documented case 68 
of lethal poisoning with polonium. 69 
 70 
Presentation 71 
On 3 November 2006, a 43-year-old man named Edwin Carter presented to the Accident and 72 
Emergency department of Barnet General Hospital (now part of Royal Free Hospital, London) 73 
complaining of abdominal pain, vomiting and diarrhoea, which had started on 1 November 2006 74 
(designated as day 1 in the following chronology). On examination, he was appeared 75 
dehydrated. He was afebrile and had a normal pulse and blood pressure. Abdominal 76 
examination revealed epigastric tenderness. Given the profuse nature of his diarrhoea, a 77 
provisional diagnosis of gastroenteritis, possibly of infective origin, was made. He was admitted 78 
for further investigation and commenced on intravenous fluids and oral ciprofloxacin 500mg 12 79 
hourly. Investigations revealed serum urea and conjugated bilirubin levels were mildly elevated 80 
at 12.1mmol/L and 49µmol/L, respectively, and creatinine high at 101µmol/L, suggesting 81 
dehydration. Haemoglobin was 201g/L (reference 120-180g/L) associated with a leucocytosis 82 
(WBC, 22x109/L, reference 4.0-11.0 x109/L) and neutrophilia (19.8x109/L, reference 2.0-7.5 83 
x109/L; Table 1). 84 
 85 
Clinical course 86 
On day 7, Clostridium difficile (C. difficile) toxin was identified in the stools by the microbiology 87 
department at Barnet General Hospital. The possibility that this may have been secondary to 88 
ciprofloxacin was raised. When the diagnosis was discussed with the patient he revealed his true 89 
identity (he had been admitted under an alias) and raised the possibility of being poisoned. He 90 
disclosed that his real name was Alexander Litvinenko and that he had defected from the 91 
Russian Security Service. Mr Litvinenko explained that on the day he became ill, he had met with 92 
former KGB agents and feared that he had been poisoned (Figure 1A and Table 1).The patient 93 
and his wife asked medical staff whether poisoning by infection with C. difficile might have 94 
occurred as they had a friend who had been killed in this way. Mr Litvinenko was commenced on 95 
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oral metronidazole (400mg three times daily) but gastrointestinal symptoms persisted. The 96 
working diagnosis was of C. difficile diarrhoea associated with a possible underlying viral 97 
gastroenteritis. By day 9, Mr Litvinenko had become neutropenic with a neutrophil count 98 
1.1x109/L (Table 1). His platelet count had also dropped from normal levels to 63x109/L. The 99 
cause for the cytopenia was unknown but thought to be due to a viral gastroenteritis or as a 100 
result of ciprofloxacin toxicity. 101 
 102 
On day 11, his neutrophil count was < 0.5x109/L and he had spiked a fever. He was commenced 103 
empirically on intravenous piperacillin/tazobactam (4.5g, 6 hourly) in order to avoid progression 104 
to a sepsis syndrome. He was also given a single dose of pegylated G-CSF (Neulasta, 6mg) to 105 
stimulate recovery of the neutrophil count. By day 13, alopecia was evident together with 106 
mucositis, this together with progressive cytopenia gave the appearance of someone who had 107 
been exposed to toxin, chemotherapy or radiation. Reverse barrier nursing was instituted and on 108 
toxicological advice from the Clinical Toxicology Unit at Guy's & St Thomas' NHS Foundation 109 
Trust, London, UK, samples were sent to for a heavy metal screen. A screen of the patient with a 110 
standard Geiger counter revealed only background values. Bone marrow trephine sample taken 111 
on day 15 was acellular (Figure 1B). He was therefore transferred to the Haematology Unit at 112 
University College London for specialist support and treatment of bone marrow failure. Samples 113 
were sent for human leukocyte antigen typing in case a bone marrow transplant was needed. On 114 
day 17 results of the heavy metal screen revealed a marginally elevated urine thallium 115 
concentration at 30nmol/L (normal <10nmol/L) but this was below the toxic concentration (800-116 
1000nmol/L). The patient had told staff that the Russians' used radioactive thallium as a poison. 117 
It was not felt likely that thallium poisoning was the cause of the patient's deterioration, 118 
particularly as there was no evidence of a peripheral neuropathy, which is a cardinal feature of 119 
thallium poisoning. However, in the absence of other clear aetiology, treatment with oral Prussian 120 
blue (Ferric ferrocyanide; 4g, 8 hourly) was commenced because of the mildly raised urine 121 
thallium level together with gastrointestinal symptoms and alopecia, two clinical features that are 122 
typically associated with thallium poisoning.  123 
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 124 
On day 18, he was jaundiced with normal alanine transaminase levels. Diarrhoea and abdominal 125 
pain were settling and his oral intake was improving although haematemesis was noted that 126 
evening. On day 19, the rapid assessment team was called because of concerns about heart 127 
rate irregularity: inverted T-waves were noted on the lateral leads of an electrocardiogram. 128 
Troponin-T levels were normal. He was, nevertheless, transferred to the intensive care unit for 129 
further monitoring. To mitigate against further abnormalities of heart rhythm, it was decided to 130 
maintain serum potassium at about 5.5mmol/L. He remained pyrexial, despite antibiotics. 131 
Because of raised inflammatory markers (C-reactive protein 100mg/ml, erythrocyte 132 
sedimentation ratio 130mm/hour) but no evidence of disseminated intravascular coagulation, he 133 
was commenced on systemic antifungal therapy with Ambisone. Repeat analyses of plasma and 134 
urine revealed a normal thallium concentration (<10nmol/L). By this stage the conjugated 135 
bilirubin level was high (230μmol/L). Over the subsequent two days (days 20-22) his renal 136 
function deteriorated rapidly (Table 1). An abdominal ultrasound scan demonstrated that the 137 
liver, spleen and kidneys were of normal size and appearance with no evidence of obstruction.  138 
 139 
The possibility of chemotherapeutic agents causing mucositis and bone marrow failure was 140 
considered but dismissed as covert administration at the doses required to cause rapid multi-141 
organ failure would have been difficult. A search for a radiotoxin was pursued along several 142 
lines, which in its simplest form entailed the exposure of the patient’s blood smear on a glass 143 
slide to an X-ray film on day 22. This speculative study revealed a surprising result in that the X-144 
ray film exposed to parts of the blood smear not covered by a glass coverslip developed opacity 145 
(Figure 1C), consistent with the presence of a radioactive substance in the blood. Later that day, 146 
gamma ray spectrometry measurements on a urine sample showed a characteristic 803 keV 147 
photon emission, raising the possibility of polonium-210 (210Po) poisoning. Further urine and 148 
blood samples were sent for confirmatory spectrometric analysis. However, the patient’s 149 
condition deteriorated rapidly that day with the onset of a florid macular skin rash, abdominal 150 
distension, progressive metabolic acidosis and oliguria. He became hypothermic (35.5oC) and 151 
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progressed to cardiogenic shock with an associated acute drop in consciousness. This was 152 
followed rapidly by a pulseless electrical activity (PEA) cardio-respiratory arrest. He was 153 
successfully resuscitated but was dependent on escalating doses of adrenaline. A further PEA 154 
cardiac arrest occurred 2 hours later. Echocardiography showed poorly contracting ventricles 155 
with no evidence of tamponade or valvular pathology. Oesophageal Doppler demonstrated a 156 
stroke volume of 40ml (normal = 70ml) despite high doses of adrenaline (2.0μg/kg/min). For the 157 
next 16 hours the patient remained unstable and required inotropes, continuous veno-venous 158 
hemofiltration and full mechanical ventilation. On day 23 Mr Litvinenko suffered a third PEA 159 
cardiac arrest and was pronounced dead. Results of the day 22 urine sample became available 160 
shortly after the patient’s death and revealed the presence of 825 becquerel (Bq)/mL of 210Po, 161 
consistent with polonium poisoning. 162 
 163 
Post-mortem results 164 
A limited post-mortem examination was conducted by a consultant forensic pathologist on day 31 165 
in the presence of a radiation protection officer. Precautions to avoid radiation exposure included 166 
the wearing of two protective suits, two pairs of gloves taped at the wrists and large battery-167 
operated plastic hoods into which filtered air was piped. Key gross macroscopic findings were 168 
the presence of blood-tinged fibrinous pericarditis, a pleural effusion associated with bilateral 169 
congestion of lungs, gross ascites and generalised tissue autolysis of most organs although the 170 
brain looked normal. Because of the hazardous nature of the tissue samples microscopy of the 171 
internal organs was not carried out and further analyses were limited to studies of the 172 
biodistribution of 210Po using gamma-ray spectrometry. The results were used to estimate total 173 
organ levels of 210Po at the time of death. As shown in Table 2, 210Po was retained in all organs 174 
and tissues, with the highest levels in the liver (30MBq/g) and kidney (49MBq/g), consistent with 175 
published data on the biodistribution of 210Po.1-3 The lower concentration of 210Po in lung tissue 176 
(3.5MBq/g) was consistent with intake largely by ingestion. Assuming ingestion of 210Po on day 1 177 
with 10% being absorbed into the systemic circulation, the measured levels of 210Po in liver, 178 
kidneys and urine were used to estimate intake as 4,400 MBq (4.4 GBq)2,3 179 
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Estimates were made of the cumulative radiation doses to the body organs of a reference 70 kg 181 
adult male over 22 days following the ingestion of 4.4 GBq of 210Po (Table 3). Radiation doses 182 
causing lethal damage to body organs are generally quantified in terms of the lethal dose of 183 
acute gamma radiation estimated to kill 50% of people so exposed (LD50values), with 184 
corresponding LD0 – LD100 ranges. Doses required to cause prodromal symptoms of vomiting 185 
and diarrhoea are expressed as effective doses (Note: LD and effective dose [ED] are 186 
toxicological terms and ED should not to be confused with the radiation protection quantity of 187 
effective dose). When estimating values for 210Po, it was necessary to take account of the 188 
reduced effectiveness of protracted irradiation and the greater damage caused per Gy by alpha 189 
particles compared to gamma rays (i.e. relative biological effectiveness for alpha particles is >1). 190 
Taking account of dose protraction and assuming a relative biological effectiveness of 2, it was 191 
estimated that the ED0 and ED50 values for vomiting and diarrhoea are about 0.6–0.8Gy and 7Gy 192 
respectively.3 Our estimated dose rate to all regions of the gut of about 0.2Gy per day for the first 193 
few days after intake (Table 3) does not, therefore, appear to be sufficient to cause the 194 
prodromal symptoms that the patient presented. However, it is possible that gut doses may have 195 
been underestimated by the model assumptions, especially as animal data suggest that a 196 
proportion of ingested 210Po is retained in the gastric and intestinal mucosa.3 Alternatively, these 197 
symptoms were due to or compounded by infection with C. difficile or cumulative radiation dose 198 
delivered by the radiotoxin in the gut lumen as well as that absorbed into the blood stream. In 199 
contrast, the estimated dose to the red bone marrow was about 6Gy after one week, rising to 200 
17Gy after 22 days. The estimated radiation doses to the liver and kidneys were also very high; 201 
respectively about 5 and 9Gy per day over the first few days and reaching 92 and 140Gy after 22 202 
days.  203 
 204 
Discussion 205 
Polonium-210 is a naturally occurring radioactive element that was discovered in 1898 by Marie 206 
Curie. It has no stable isotopes and decays by emitting a large quantity of alpha particles, which 207 
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cause excitation in the nucleus and emission of gamma rays with a maximum energy of 803 keV. 208 
It has a half-life of 138 days and high specific activity, so that a very small mass corresponds to a 209 
high level of radioactivity. Humans are constantly exposed to 210Po, which is found at low 210 
concentrations in the environment as part of the uranium decay chain. However, annual intake 211 
from natural sources is about 109 times less than the intake estimated in our subject at around 4 212 
GBq. 213 
 214 
Polonium is used in various industrial applications and as a power supply in small satellites but 215 
its manufacture requires sophisticated equipment. It is, therefore, not widely available. However, 216 
it is an effective poison for several reasons. It forms water soluble, colourless salts that are 217 
readily absorbed across biological membranes, becoming widely distributed in body organs and 218 
tissues where the alpha particles deliver a large amount of energy to surrounding cells resulting 219 
in cell death and organ damage. Early symptoms of 210Po poisoning are indistinguishable from 220 
those of a wide range of chemical toxins. Therefore, the diagnosis can be delayed and even 221 
missed without a high level of suspicion. Furthermore, 210Po can be transported easily and safely 222 
without detection because its high-energy alpha particles have a short range and can be blocked 223 
by a relatively thin barrier including the skin, while the associated gamma ray emissions are very 224 
low yield. Hence, the use of a Geiger counter in this case was unable to detect the radiation 225 
emitted by 210Po. Alpha-particle spectroscopy represents the best way to test for radiotoxins such 226 
as 210Po which emit alpha particles. These instruments are not readily available in the majority of 227 
hospitals.  228 
 229 
Reports on human subjects are limited; a Russian accident case involving inhalation of an 230 
aerosol of 210Po at an approximate dose of 530 MBq 210Po resulted in death in 13 days.3,4 The 231 
time-course of rapid clinical deterioration observed in our patient, resulting in death within 23 232 
days, is, however, consistent with animal data for a number of mammalian species.3 Aside from 233 
the gastro-intestinal tract, the bone marrow was among the first organ systems to be damaged. 234 
From an initial neutrophilia, a feature of acute radiation injury,5 the neutrophil count declined 235 
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rapidly over a two week period. The LD50 for the bone marrow was estimated to be about 3Gy, 236 
with an LD0 – LD100 range of 1-4Gy. Our calculations indicate that the LD100 value for the red 237 
bone marrow was exceeded after 5 days (Table 3), causing irreversible damage to the 238 
hematopoietic stem cell and stromal compartments.3 At significantly lower doses of 210Po, 239 
transplanted progenitor cells may provide transient support but animal data indicate that death in 240 
such a setting may occur at later times, predominantly as a consequence of radiation damage to 241 
the kidneys.6 Similarly, the estimated LD50 value for acute kidney damage was 6Gy, with a 242 
corresponding value for liver failure of 8Gy. Our estimates of the cumulative dose delivered to 243 
the kidney and liver were 44 and 28Gy respectively at day 5. Hence, the wide distribution of 244 
210Po likely resulted in the delivery of lethal radiation doses to a number of organs at an early 245 
stage after intake.  246 
 247 
A number of chelating agents have been assessed in animal models of 210Po poisoning to reduce 248 
organ retention and enhance excretion.7,8 Unithiol (sodium 2,3-dimercaptopropane-1-sulphonate) 249 
has been used in children accidentally exposed to 210Po in the former Soviet Union9 and has 250 
recently been given to two individuals thought to have been exposed at around the same time as 251 
Mr Litvinenko: both survived but had received considerably lower doses of 210Po than our patient. 252 
Animal data suggest that chelation may decrease 210Po retention in the blood, spleen and bone, 253 
although this may be associated with increased retention in the kidneys and the brain. Typically 254 
the amounts used in animal studies are generally higher than recommended for administration to 255 
humans.  256 
 257 
Conclusion 258 
This case has raised our awareness of the possibility that radioactive materials may be used as 259 
poisons with catastrophic effect. Importantly, early symptoms of 210Po poisoning were 260 
indistinguishable from those of a wide range of chemical toxins, including thallium, thus causing 261 
a delay in diagnosis. Additionally, body surface scanning with a standard Geiger counter was 262 
unable to detect the alpha radiation emitted by 210Po. Nevertheless, an atypical clinical course 263 
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including mucositis, alopecia and bone marrow failure prompted active consideration of 264 
poisoning with radioactive material, with the diagnosis being ultimately made with gamma-ray 265 
spectroscopy of a urine sample. An earlier diagnosis in our patient would not have enabled him 266 
to survive as the high level of 210Po absorbed and distributed to body organs within hours of 267 
intake would have resulted in rapid cell death and multiple organ failure. Preparedness for such 268 
cases in the future would require a high level of clinical suspicion and investment in sensitive 269 
detection instrumentation by hospitals. However, such cases would remain untreatable without 270 
research into effective antidotes that reduce levels and biodistribution of 210Po, and limit the 271 
extent of organ damage. Nevertheless, early diagnosis of poisoning with radiotoxin is important 272 
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Liver and Renal Biochemistry 



















  3 201 21.7 19.8 1.0 178 49 16 12.1 101 
  4  -- -- -- --     
  5 149 17.2 16.1 0.6 105   7.9 76 
  6  -- -- -- --     
  7 130 7.1 6.8 0.1 92   4.4 79 
  8  -- -- -- --     
  9 129 1.3 1.1 0.0 63 66 50 4.6 76 
10  -- -- -- --     
11 136 0.3 0.3 0.0 35 60 92 4.4 90 
12 147 0.2 0.1 0.0 21 69 107   
13 145 0.1 0.0 0.0 9 76 102   
14 113 0.0 0.0 0.0 2*   10 102 
15  0.0 0.0 0.0 17     
16  0.0 0.0 0.0 21     
17  0.0 0.0 0.0 13     
18 91 0.1 0.0 0.0 10 153 40 9.2 132 
19 84 0.01 0.0 0.0 7 181 34 9.8 133 
20 91 0.01 0.0 0.0 15 228 39 11.8 190 
21 82 0.05 0.0 0.0 18 242 48 16.6 218 
22 90 0.01 0.0 0.0 8 254 54 23.9 286+ 
23 108 0.02 0.0 0.0 15 158 112 24 353+ 
          
Normal 120-180 4 - 11 2.0 – 7.5 1.0 – 4.0 150 - 400 3-20 
 






WBC = white blood cells. ALT = Alanine Transaminase   + Enzymatic creatinine 
*Platelet and plasma transfusions started. 
Table 1. Progression of the patient’s haematological parameters and hepatic and renal biochemistry after suspected poisoning, day 1 
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Table 2. Measurements of polonium-210 in post-mortem samples, blood and urine, 










activity in organ/ 
tissue,  MBqa 
 
Model prediction of 










Brain 5500 8 - 
Lung 3500 1.8 - 
Spleen 9900 1.5 4.5 
Kidney  49000 15 17 
Bile 13000 3 – 14 per day 4d 
Liver 30000 54 66 
Heart  2500 2e - 
Skin 1800 6 35 
Blood: day 20  3300 19 25 
Blood: day 23 1500 8 23 
Urine: day 22 825 per ml 1.3 1.0 
 
aScaled from measurements using data for organ masses, and blood, urine and bile 
volumes.(10) 
bAn estimate of intake by ingestion of 4.4 GBq 210Po on day 1, assuming 10% 
absorption to blood, was made based on the most reliable measurements (urine, liver 
and kidneys) using a model for the behavior of polonium-210 in the body(2)and the 
model was then used to calculate the tabulated values.  
cAssuming that the concentration of polonium-210 in muscle is representative of 
“Other” tissues in the model.(2) 
dBased on the assumption that biliary excretion accounts for all fecal excretion. 
eIncluding blood content. 
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Table 3. Cumulative doses to organs / tissues of a reference adult male after 

























2 1.8 0.4 11 18 6.4 1.3 1.9 
3 2.7 0.6 17 27 9.9 2.0 2.9 
4 3.6 0.8 22 36 13 2.8 4.1 
5 4.5 1.1 28 44 16 3.6 5.2 
10 8.7 2.0 51 80 31 7.9 12 
15 12 2.8 70 110 44 13 19 
20 16 3.5 86 130 55 18 26 
22 17 3.7 92 140 59 20 29 
 
1 Bq = 1 dissociation per second (releasing one alpha particle per second, with 









Figure 1B: H&E stained bone marrow trephine showing cartilage and adipocytes with 




Figure 1C: X-ray film (Right image) exposed to the patient’s blood smear (Left Image) 
showing opacification (red arrow) in the exposed area of the smear but not in the 
adjacent area that was covered by a glass coverslip (Blue arrow) 
 
 
 
 
 
 
 
 
